# India Single Photon Emission Computed Tomography Market > India Single Photon Emission Computed Tomography Market Research Report: Size, Share, Trend Analysis By Types (Hybrid SPECT Systems, Standalone SPECT System), By Applications (Oncology, Cardiology, Neurology) and By End Users (Hospitals, Diagnostic Imaging Centers) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.24% - **2024:** $ 85.52 Million - **2025:** $ 91.71 Million - **2035:** $ 184.56 Million - **Key Players:** GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Elekta (SE), Medtronic (US), Hitachi Medical Corporation (JP), Nuclear Imaging (US) **Report ID:** MRFR/HC/48647-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/india-single-photon-emission-computed-tomography-market-50404 --- ## Market Summary ## **India Single Photon Emission Computed Tomography Market Overview** As per MRFR analysis, the India Single Photon Emission Computed Tomography Market Size was estimated at 79.98 (USD Million) in 2023.The India Single Photon Emission Computed Tomography Market Industry is expected to grow from 85.5(USD Million) in 2024 to 131 (USD Million) by 2035. The India Single Photon Emission Computed Tomography Market CAGR (growth rate) is expected to be around 3.955% during the forecast period (2025 - 2035) **Key India Single Photon Emission Computed Tomography Market Trends Highlighted** The India Single Photon Emission Computed Tomography Market is experiencing advanced changes due to increased emission focus in healthcare. India’s enhancing infrastructure is a healthcare gating driver, supplemented by the government’s National Health Mission scheme which seeks to spatially improve diagnostic services within the country. Improvement in the healthcare facilities has increased investment in medical imaging technology such as SPECT, to aid the early detection of diseases, improve patient outcomes and maintain better standards. In addition, the shift focus on chronic diseases such as heart-related diseases and cancer has increased need for strong imaging systems, which in return escalated the demand for SPECT systems. The integration of AI and machine learning technologies in SPECT imaging is presenting new paths for innovation and development. These technologies offer better image processing, lesser diagnostic errors, and improved workflow in nuclear medicine practices in India. This grabs the attention of healthcare providers and investors. Also, the shift towards personalized medicine is impacting the market because SPECT imaging facilitates individualized treatment design which helps in directing patient care towards patients. Recently, there has been a remarkable rise in the partnerships between hospitals and medical tech companies to enhance the affordability and accessibility of SPECT imaging services. The public-private partnership policies in the healthcare system of the government are opening new frontiers for advanced imaging solutions in the underdeveloped regions. Hence, these factors are rapidly evolving the India Single Photon Emission Computed Tomography market for sustained growth potential in the evolution of healthcare trends and emerging opportunities. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **India Single Photon Emission Computed Tomography Market Drivers** **Increasing Prevalence of Cancer in India** The growing prevalence of cancer in India serves as a significant driver for the India Single Photon Emission Computed Tomography Market Industry. According to data from the National Cancer Registry Programme, the estimated annual incidence of cancer cases in India is around 1.16 million, with more than 5 lakh annual deaths due to various forms of cancer. This alarming trend is pushing the demand for advanced diagnostic imaging techniques, including Single Photon Emission Computed Tomography (SPECT), to facilitate early detection and effective treatment strategies. Renowned organizations such as the Tata Memorial Hospital and the Indian Council of Medical Research are increasingly emphasizing the importance of integrating advanced imaging technologies like SPECT in routine clinical practices to ensure better diagnostic accuracy and patient outcomes, thereby driving market growth in the India Single Photon Emission Computed Tomography Market. **Technological Advancements in Imaging Techniques** The rapid advancements in imaging technologies are significantly influencing the India Single Photon Emission Computed Tomography Market Industry. Innovations such as hybrid imaging systems, which combine Single Photon Emission Computed Tomography with computed tomography for improved spatial resolution, have been developed. According to the Indian Medical Association, the adoption of these advanced technologies has increased by over 30% in urban healthcare facilities in the last five years. Leading institutions like All India Institute of Medical Sciences are actively involved in pioneering research and the implementation of new technologies, ensuring that the healthcare sector remains aligned with global standards. This focus on technological progress is set to substantially foster market growth. **Government Initiatives and Health Policies** Government initiatives aimed at enhancing healthcare infrastructure and access to diagnostic technologies significantly bolster the India Single Photon Emission Computed Tomography Market. The National Health Mission, launched by the Government of India, aims to reduce premature mortality due to non-communicable diseases by promoting comprehensive diagnostic approaches, including imaging services. Increased public health spending, projected to grow by approximately 2.5% of GDP by 2025, underscores the government's commitment to advancing diagnostic facilities.By improving access to advanced imaging technologies such as SPECT, this initiative is expected to impact the India Single Photon Emission Computed Tomography Market positively. **Rising Geriatric Population** The rapid increase in the geriatric population in India is a key driver of the India Single Photon Emission Computed Tomography Market Industry. According to the United Nations, the population aged 60 years and above is projected to reach 340 million by 2050, resulting in a higher incidence of age-related health issues, including cancer and cardiovascular diseases that necessitate advanced diagnostic techniques. The Geriatric Society of India has highlighted that older adults often require comprehensive diagnostic assessments, leading to a greater reliance on imaging modalities like Single Photon Emission Computed Tomography.The growing awareness and demand for specialized diagnostic services further underscores the potential for market growth in this segment. **India Single Photon Emission Computed Tomography Market Segment Insights** **Single Photon Emission Computed Tomography Market Type Insights** The India Single Photon Emission Computed Tomography Market is characterized by significant advancements in imaging technologies, particularly within the Type segmentation that includes Hybrid SPECT Systems and Standalone SPECT Systems. Hybrid SPECT Systems are emerging as a critical component of the market due to their ability to combine different imaging modalities, such as SPECT and CT, providing improved diagnostic capabilities that enhance treatment planning for various diseases, including cancers and cardiovascular disorders. As healthcare institutions aim to deliver comprehensive patient care, the integration of these systems into clinical practice is increasingly recognized for its value in enhancing diagnostic accuracy and patient management. On the other hand, Standalone SPECT Systems maintain a strong presence in several medical applications owing to their simplicity and effectiveness in delivering high-quality imaging without the need for additional modalities. These systems often dominate in facilities where budget constraints prevail, offering essential functionality for routine diagnostic procedures. Both segments play an important role in catering to the diverse needs of hospitals and diagnostic centers across India, reflecting the broader trend of growing healthcare infrastructure and increasing disease prevalence in the country. Furthermore, the rising geriatric population and the associated growth in chronic diseases are projected to spur demand for both Hybrid and Standalone SPECT Systems, creating ample opportunities for advancements in technology and improved healthcare delivery. Overall, innovations in SPECT technology and the ongoing development in imaging solutions position the India Single Photon Emission Computed Tomography Market for considerable growth as healthcare adapts to meet evolving patient needs. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Single Photon Emission Computed Tomography Market Application Insights** The India Single Photon Emission Computed Tomography Market is witnessing significant growth across various applications, particularly in Oncology, Cardiology, and Neurology. Oncology is a major focus area, as the rising incidence of cancer in India creates a demand for advanced diagnostic tools to ensure early detection and effective treatment. Similarly, Cardiology has emerged as a vital application owing to the increasing prevalence of cardiovascular diseases, necessitating specialized imaging techniques to assess heart function and blood flow. Neurology, on the other hand, plays a crucial role in diagnosing neurodegenerative disorders, brain tumors, and other neurological conditions, highlighting the importance of precise imaging in treatment planning and monitoring. The growing emphasis on early diagnosis and personalized treatment options in India drives the expansion of these applications within the market. The advent of technological advancements and increasing healthcare investments are further supporting the evolution of the India Single Photon Emission Computed Tomography Market, enhancing patient outcomes and optimizing healthcare resources throughout the country. **Single Photon Emission Computed Tomography Market End User Insights** The End User segment in the India Single Photon Emission Computed Tomography Market holds significant importance as it primarily comprises Hospitals and Diagnostic Imaging Centers, which are pivotal in leveraging advanced imaging technologies. Hospitals play a crucial role in providing comprehensive healthcare services and have adapted to modern diagnostic practices, adopting Single Photon Emission Computed Tomography for its efficacy in diagnosing various conditions. Diagnostic Imaging Centers serve as specialized facilities that enhance patient access to advanced imaging techniques, thereby fostering early diagnosis and treatment. The increasing prevalence of chronic diseases and growing awareness of early detection strategies are driving higher utilization rates in these settings. Furthermore, advancements in technology and the introduction of new imaging modalities are expected to enhance the operational capabilities of these facilities, underpinning their dominance in the India Single Photon Emission Computed Tomography Market. This segment remains a focus area for investment and development as healthcare providers seek to improve diagnostic accuracy and patient outcomes in the country. **India Single Photon Emission Computed Tomography Market Key Players and Competitive Insights** The competitive landscape of the India Single Photon Emission Computed Tomography Market showcases a rapidly evolving sector, driven by technological advancements and an increasing demand for diagnostic imaging solutions. The market is characterized by a diverse range of players that offer innovative products and services tailored to the needs of healthcare providers and institutions. With the growing prevalence of chronic diseases and an aging population, the applicability of single photon emission computed tomography (SPECT) in clinical settings is expanding, leading to intensified competition among market participants. Strategic collaborations, product launches, and investment in research and development are some of the tactical moves companies are employing to strengthen their foothold in this niche market.  The competitive dynamics also indicate a shift towards enhanced patient outcomes and cost-effective solutions, influencing the market strategies of key players.Bayer has established a formidable presence in the India Single Photon Emission Computed Tomography Market through its extensive expertise in healthcare and pharmaceuticals. The company's strength lies in its robust research and development frameworks, enabling it to bring advanced diagnostic imaging solutions to the market. Bayer has a strong brand reputation and is known for its commitment to quality and innovation, which resonates well with healthcare professionals and institutions. Furthermore, the company’s strategic partnerships with medical institutions and research organizations bolster its capabilities to develop tailored solutions in the SPECT space.  It harnesses its global experience while adapting strategies that cater specifically to the Indian market, allowing Bayer to strategically position itself among top competitors.Lantheus Medical Imaging, on the other hand, is a significant player in the India Single Photon Emission Computed Tomography Market, specializing in diagnostic imaging solutions. The company offers a range of key products, including radiopharmaceuticals that support SPECT imaging, addressing various clinical needs. Its strengths lie in its focus on innovation and dedication to improving patient care outcomes. Lantheus has been actively expanding its market presence through strategic mergers and acquisitions, allowing it to enhance its product portfolio and capability in the Indian healthcare landscape.  Collaborations with local healthcare providers and existing global partnerships enable Lantheus to leverage its expertise in nuclear medicine, further solidifying its position in the market. Through its commitment to research and development, the company continues to push the boundaries of what is achievable in diagnostic imaging, positioning itself as a reliable contributor to the evolving landscape of the India Single Photon Emission Computed Tomography Market. **Key Companies in the India Single Photon Emission Computed Tomography Market Include** **India Single Photon Emission Computed Tomography Market Industry Developments** The India Single Photon Emission Computed Tomography (SPECT) market has witnessed significant developments recently, particularly with substantial growth driven by advancements in medical imaging technologies. Companies like Bayer and Siemens Healthineers are focusing on innovations in pharmaceuticals and imaging equipment, enhancing diagnostic capabilities. Philips Healthcare has been expanding its portfolio with improved SPECT technologies evaluating patient care's efficiency. In September 2023, Lantheus Medical Imaging announced collaborative efforts for enhanced market penetration in the region, potentially increasing access to SPECT imaging. Major acquisitions have also shaped the landscape, notably Bracco Imaging's acquisition of a local imaging firm in August 2023 to boost its presence in the rapidly growing Indian market.  The recent emphasis on early diagnosis of various health conditions, such as cardiac diseases, is driving up the demand for SPECT imaging solutions. The market is expected to reach greater valuations, propelled by the increasing prevalence of chronic diseases and a growing focus on tailored healthcare solutions. Simultaneously, government initiatives promoting healthcare infrastructure enhancement and research are positively influencing market growth, reflecting India’s commitment to advancing medical technology and imaging services. **India Single Photon Emission Computed Tomography Market Segmentation Insights** ## Market Drivers ### Rising Healthcare Expenditure India's healthcare expenditure has been on an upward trajectory, which is expected to positively influence the single photon-emission-computed-tomography market. With the government aiming to increase public health spending to 2.5% of GDP by 2025, there is a growing allocation of funds towards advanced medical technologies. This financial commitment is likely to facilitate the procurement of sophisticated imaging equipment, including SPECT systems, in hospitals and diagnostic centers. As healthcare facilities upgrade their infrastructure to meet the increasing demand for quality healthcare services, the single photon-emission-computed-tomography market stands to benefit significantly. The enhanced availability of SPECT technology may lead to improved diagnostic accuracy and patient care, further driving market growth. ### Growing Awareness of Early Diagnosis There is a notable increase in awareness regarding the importance of early diagnosis among the Indian population, which is likely to propel the single photon-emission-computed-tomography market. Public health campaigns and educational initiatives are emphasizing the benefits of early detection of diseases, particularly in oncology and cardiology. This heightened awareness is encouraging patients to seek advanced diagnostic services, including SPECT imaging, which is known for its ability to provide detailed functional information about organs. As more individuals opt for preventive healthcare measures, the demand for SPECT technology is expected to rise, thereby contributing to the growth of the market in India. ### Technological Innovations in Imaging Technological advancements in imaging modalities are transforming the landscape of the single photon-emission-computed-tomography market. Innovations such as hybrid imaging systems, which combine SPECT with CT or MRI, are enhancing diagnostic capabilities and improving patient outcomes. These advancements allow for more accurate localization of diseases and better assessment of treatment responses. The introduction of new radiopharmaceuticals is also expanding the applications of SPECT imaging, making it a versatile tool in oncology and cardiology. As healthcare providers in India increasingly adopt these technologies, the single photon-emission-computed-tomography market is likely to experience substantial growth, driven by the demand for more effective diagnostic solutions. ### Expansion of Diagnostic Imaging Centers The expansion of diagnostic imaging centers across India is a crucial driver for the single photon-emission-computed-tomography market. With an increasing number of private and public healthcare facilities investing in advanced imaging technologies, access to SPECT imaging is becoming more widespread. This trend is particularly evident in tier-2 and tier-3 cities, where the establishment of new diagnostic centers is improving healthcare accessibility. As these centers adopt state-of-the-art SPECT systems, the market is likely to witness significant growth. The proliferation of diagnostic imaging centers not only enhances patient access to advanced diagnostic tools but also fosters competition, potentially leading to improved service quality and affordability in the single photon-emission-computed-tomography market. ### Increasing Prevalence of Chronic Diseases The rising incidence of chronic diseases in India, such as cardiovascular disorders and cancer, is a primary driver for the single photon-emission-computed-tomography market. As healthcare providers seek advanced diagnostic tools to improve patient outcomes, the demand for SPECT imaging is likely to increase. According to recent estimates, chronic diseases account for approximately 60% of all deaths in India, highlighting the urgent need for effective diagnostic solutions. The single photon-emission-computed-tomography market is positioned to address this need, offering precise imaging capabilities that aid in early detection and treatment planning. Furthermore, the integration of SPECT with other imaging modalities may enhance its utility, potentially leading to a broader adoption in clinical settings across the country. ## Future Outlook The single photon-emission-computed-tomography market in India is projected to grow at a 7.24% CAGR from 2025 to 2035, driven by technological advancements and increasing healthcare investments. **New opportunities:** - Development of portable SPECT devices for remote diagnostics. - Partnerships with healthcare providers for integrated imaging solutions. - Expansion into emerging markets with tailored SPECT services. By 2035, the market is expected to achieve substantial growth, positioning itself as a leader in advanced imaging technologies. ## Segment Insights ### By Type: Hybrid SPECT Systems (Largest) vs. Standalone SPECT System (Fastest-Growing) In the India single photon-emission-computed-tomography market, Hybrid SPECT Systems hold the largest market share among the type segment, demonstrating substantial adoption across various healthcare facilities. This segment's comprehensive capabilities in combining SPECT with other imaging modalities enhance its appeal and utility. On the other hand, Standalone SPECT Systems are witnessing rapid growth, particularly in smaller institutions where budget constraints are prevalent, indicating a shift towards cost-effective imaging solutions that maintain quality without the additional features of hybrid systems. The growth trends in the India single photon-emission-computed-tomography market highlight the rising demand for Standalone SPECT Systems due to their accessibility and the increasing focus on diagnostic accuracy. Factors driving this segment include technological advancements and a growing emphasis on early disease detection. As healthcare providers seek to expand their imaging capabilities, Hybrid SPECT Systems are expected to continue dominating the market while Standalone SPECT Systems emerge as a vital option for efficient imaging in budget-sensitive settings. Hybrid SPECT Systems (Dominant) vs. Standalone SPECT System (Emerging) Hybrid SPECT Systems are characterized by their ability to integrate multiple imaging modalities, providing enhanced diagnostic insights and improving patient outcomes. Their dominant position in the market is driven by advancements in imaging technology and increasing preference for comprehensive diagnostic solutions. These systems are favored in large hospitals and research institutions due to their versatility and enhanced imaging capabilities. In contrast, Standalone SPECT Systems are gaining traction as an emerging segment, primarily due to their cost-effectiveness and simplicity, making them ideal for smaller healthcare facilities or those with budget constraints. They enable essential imaging functions without the complexities associated with hybrid systems, appealing to a segment of the market that prioritizes efficiency and affordability. ### By Application: Oncology (Largest) vs. Cardiology (Fastest-Growing) The market share distribution in the Application segment reveals that Oncology is the dominant force, capturing the largest share of the total market. Following it, Cardiology exhibits significant interest from healthcare providers and institutions, which is reflective of the rising demand for advanced diagnostic tools in this field. Neurology, while essential, follows behind in terms of market share, indicating a more specialized focus that is yet to reach the levels of the other two applications. Growth trends in the India single photon-emission-computed-tomography market suggest that Cardiology is on the path to becoming the fastest-growing segment due to an increasing prevalence of cardiovascular diseases and a push for innovative imaging solutions. Additionally, the awareness and early detection of oncological conditions fuel the continuous demand for Oncology applications. These growth drivers are likely to pave the way for future advancements in imaging technologies. Oncology (Dominant) vs. Cardiology (Emerging) Oncology is recognized as the dominant application within the market, driven by its widespread utilization in cancer detection and management. With a focus on tumor visualization and metabolism assessment, it leverages advanced technologies to improve patient outcomes. Conversely, Cardiology, while currently emerging, is gaining traction due to the rising incidence of heart-related disorders and a growing emphasis on preventive healthcare. This segment thrives on the development of novel imaging techniques that enhance diagnostic accuracy and patient management. Neurology remains vital as well but tends to cater to a more niche audience, focusing on conditions like epilepsy and brain tumors, leading to varying growth prospects. ### By End-User: Hospitals (Largest) vs. Diagnostic Imaging Centers (Fastest-Growing) In the India single photon-emission-computed-tomography market, hospitals hold the largest share, reflecting their extensive resources and capabilities for advanced medical imaging. These facilities are often equipped with the latest technology, providing a wide range of diagnostic services, which creates a robust demand for single photon-emission-computed-tomography equipment. In contrast, diagnostic imaging centers are gaining ground rapidly, driven by increasing patient volume and the expansion of outpatient services, catering to specific imaging needs more efficiently. The growth trends in this segment are fueled by the rising prevalence of chronic diseases and an aging population that demands more advanced diagnostic capabilities. Hospitals continue to expand their imaging departments to accommodate technological advancements and enhance patient care. Meanwhile, diagnostic imaging centers are becoming critical players in the market, offering fast and specialized imaging solutions that attract patients seeking convenient and accessible healthcare options. As healthcare systems evolve, both segments are expected to play pivotal roles in shaping the future of diagnostic imaging in India. Hospitals (Dominant) vs. Diagnostic Imaging Centers (Emerging) Hospitals represent the dominant segment in the India single photon-emission-computed-tomography market, characterized by comprehensive care facilities equipped with state-of-the-art imaging technologies. They serve a diverse patient demographic, offering extensive services and specialized treatments, which drive their demand for single photon-emission-computed-tomography systems. In contrast, diagnostic imaging centers are emerging as a vital component of the healthcare landscape, providing targeted imaging services that cater to the growing need for specific diagnostic procedures. These centers often prioritize efficiency and patient convenience, operating on a more streamlined model that can quickly adapt to changing market demands. With the ongoing pressure for healthcare providers to optimize outcomes, both segments are poised to make substantial contributions to the market's expansion. ## Competitive Benchmarking The [single photon-emission-computed-tomography](https://www.marketresearchfuture.com/reports/single-photon-emission-computed-tomography-market-7231) market in India is characterized by a competitive landscape that is increasingly shaped by technological advancements and strategic collaborations. Key players such as GE Healthcare (US), Siemens Healthineers (DE), and Philips Healthcare (NL) are at the forefront, leveraging innovation and regional expansion to enhance their market presence. GE Healthcare (US) has focused on integrating advanced imaging technologies into its offerings, which appears to resonate well with the growing demand for precise diagnostic tools. Siemens Healthineers (DE) emphasizes partnerships with local healthcare providers, aiming to tailor solutions that meet specific regional needs, while Philips Healthcare (NL) is investing in digital transformation initiatives to streamline operations and improve patient outcomes. Collectively, these strategies contribute to a dynamic competitive environment, where innovation and localized solutions are paramount. In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure is moderately fragmented, with several players vying for market share, yet the influence of major companies remains substantial. This competitive structure allows for a diverse range of products and services, catering to various segments of the healthcare market in India. In October 2025, Siemens Healthineers (DE) announced a strategic partnership with a leading Indian hospital chain to develop a network of advanced imaging centers. This collaboration is expected to enhance access to cutting-edge diagnostic services across the region, thereby positioning Siemens as a key player in the local market. The strategic importance of this partnership lies in its potential to significantly increase patient throughput and improve diagnostic accuracy, aligning with the growing emphasis on quality healthcare delivery. In September 2025, Philips Healthcare (NL) launched a new line of advanced SPECT imaging systems designed specifically for the Indian market. This launch is indicative of Philips' commitment to addressing local healthcare challenges through tailored solutions. The introduction of these systems is likely to enhance diagnostic capabilities, thereby improving patient care and solidifying Philips' competitive edge in the region. In November 2025, GE Healthcare (US) unveiled a new initiative aimed at integrating artificial intelligence into its imaging systems. This move is seen as a response to the increasing demand for AI-driven solutions in healthcare, which could potentially streamline workflows and enhance diagnostic accuracy. The strategic importance of this initiative lies in its alignment with global trends towards digitalization and the growing need for efficient healthcare solutions. As of November 2025, the competitive trends in the single photon-emission-computed-tomography market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are playing a crucial role in shaping the current landscape, enabling companies to leverage shared resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition towards a focus on innovation, technological advancements, and supply chain reliability. This shift underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive edge in the market. ## Recent News & Developments The India Single Photon Emission Computed Tomography Market (SPECT) market has witnessed significant developments recently, particularly with substantial growth driven by advancements in medical imaging technologies. Companies like Bayer and Siemens Healthineers are focusing on innovations in pharmaceuticals and imaging equipment, enhancing diagnostic capabilities. Philips Healthcare has been expanding its portfolio with improved SPECT technologies evaluating patient care's efficiency. In September 2023, Lantheus Medical Imaging announced collaborative efforts for enhanced market penetration in the region, potentially increasing access to SPECT imaging. Major acquisitions have also shaped the landscape, notably Bracco Imaging's acquisition of a local imaging firm in August 2023 to boost its presence in the rapidly growing Indian market.  The recent emphasis on early diagnosis of various health conditions, such as cardiac diseases, is driving up the demand for SPECT imaging solutions. The market is expected to reach greater valuations, propelled by the increasing prevalence of chronic diseases and a growing focus on tailored healthcare solutions. Simultaneously, government initiatives promoting healthcare infrastructure enhancement and research are positively influencing market growth, reflecting India’s commitment to advancing medical technology and imaging services. ## Report Scope | MARKET SIZE 2024 | 85.52(USD Million) | | --- | --- | | MARKET SIZE 2025 | 91.71(USD Million) | | MARKET SIZE 2035 | 184.56(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.24% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Elekta (SE), Medtronic (US), Hitachi Medical Corporation (JP), Nuclear Imaging (US) | | Segments Covered | Type, Application, End-User | | Key Market Opportunities | Advancements in imaging technology enhance diagnostic accuracy in the single photon-emission-computed-tomography market. | | Key Market Dynamics | Technological advancements and regulatory changes drive growth in the single photon-emission-computed-tomography market. | | Countries Covered | India | ## Frequently Asked Questions **Q: What was the market valuation of the India single photon-emission-computed-tomography market in 2024?** A: The market valuation was $85.52 Million in 2024. **Q: What is the projected market valuation for the India single photon-emission-computed-tomography market by 2035?** A: The projected valuation for 2035 is $184.56 Million. **Q: What is the expected CAGR for the India single photon-emission-computed-tomography market during the forecast period 2025 - 2035?** A: The expected CAGR during this period is 7.24%. **Q: Which companies are the key players in the India single photon-emission-computed-tomography market?** A: Key players include GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Elekta, Medtronic, Hitachi Medical Corporation, and Nuclear Imaging. **Q: What are the main types of systems in the India single photon-emission-computed-tomography market?** A: The main types are Hybrid SPECT Systems and Standalone SPECT Systems. **Q: What was the market size for Hybrid SPECT Systems in 2024?** A: The market size for Hybrid SPECT Systems was $50.0 Million in 2024. **Q: What is the projected market size for Standalone SPECT Systems by 2035?** A: The projected market size for Standalone SPECT Systems by 2035 is $74.56 Million. **Q: Which applications dominate the India single photon-emission-computed-tomography market?** A: The dominant applications are Oncology, Cardiology, and Neurology. **Q: What was the market size for Cardiology applications in 2024?** A: The market size for Cardiology applications was $30.0 Million in 2024. **Q: What is the expected market size for hospitals as end-users by 2035?** A: The expected market size for hospitals as end-users by 2035 is $110.0 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-single-photon-emission-computed-tomography-market-50404*